{"entity":{"type":"insider","cik":"0001652044","url":"/insider/0001652044","json_url":"/insider/0001652044.json","name":"Alphabet Inc.","name_source":"as-filed","also_issuer":true,"cross_url":"/issuer/0001652044"},"coverage_statement":{"n_transactions":312,"n_filings":59,"first":"2019-06-18","last":"2026-07-29","span_basis":"filed_date"},"name_variants":[{"name":"Alphabet Inc.","source":"filing","n_filings":59,"first_seen":"2019-06-18","last_seen":"2026-07-29"}],"transactions":[{"id":5977592,"accession":"0001168404-26-000041","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001168404-26-000041","line_url":"/filing/0001168404-26-000041#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":118138.0,"shares_display":"118,138","price_per_share":18.8996,"price_display":"18.90","price_state":"stated","total_value":2232760.9448,"total_display":"2,232,760.94","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-28","filed_date":"2026-07-29","scope":"insider"},{"id":5977583,"accession":"0001168404-26-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001168404-26-000041","line_url":"/filing/0001168404-26-000041#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":196931.0,"shares_display":"196,931","price_per_share":19.4629,"price_display":"19.46","price_state":"stated","total_value":3832848.3599,"total_display":"3,832,848.36","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-27","filed_date":"2026-07-29","scope":"insider"},{"id":5846513,"accession":"0001168404-26-000039","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001168404-26-000039","line_url":"/filing/0001168404-26-000039#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; Alphabet Inc.; GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23417.0,"shares_display":"23,417","price_per_share":18.8752,"price_display":"18.88","price_state":"stated","total_value":442000.5584,"total_display":"442,000.56","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-24","filed_date":"2026-07-27","scope":"insider"},{"id":5846509,"accession":"0001168404-26-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001168404-26-000039","line_url":"/filing/0001168404-26-000039#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; Alphabet Inc.; GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63297.0,"shares_display":"63,297","price_per_share":19.0573,"price_display":"19.06","price_state":"stated","total_value":1206269.9181,"total_display":"1,206,269.92","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-23","filed_date":"2026-07-27","scope":"insider"},{"id":5883433,"accession":"0001168404-26-000036","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001168404-26-000036","line_url":"/filing/0001168404-26-000036#line-5","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49582.0,"shares_display":"49,582","price_per_share":19.2301,"price_display":"19.23","price_state":"stated","total_value":953466.8182,"total_display":"953,466.82","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-22","filed_date":"2026-07-23","scope":"insider"},{"id":5883429,"accession":"0001168404-26-000036","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001168404-26-000036","line_url":"/filing/0001168404-26-000036#line-3","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22700.0,"shares_display":"22,700","price_per_share":19.0495,"price_display":"19.05","price_state":"stated","total_value":432423.65,"total_display":"432,423.65","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-21","filed_date":"2026-07-23","scope":"insider"},{"id":5883426,"accession":"0001168404-26-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001168404-26-000036","line_url":"/filing/0001168404-26-000036#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":19.72,"price_display":"19.72","price_state":"stated","total_value":3944.0,"total_display":"3,944.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-21","filed_date":"2026-07-23","scope":"insider"},{"id":5957642,"accession":"0001168404-26-000031","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001168404-26-000031","line_url":"/filing/0001168404-26-000031#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2021, L.P.; GV 2019 GP, L.P.; Alphabet Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18386.0,"shares_display":"18,386","price_per_share":18.8654,"price_display":"18.87","price_state":"stated","total_value":346859.2444,"total_display":"346,859.24","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-20","filed_date":"2026-07-21","scope":"insider"},{"id":5957637,"accession":"0001168404-26-000031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001168404-26-000031","line_url":"/filing/0001168404-26-000031#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2021, L.P.; GV 2019 GP, L.P.; Alphabet Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20534.0,"shares_display":"20,534","price_per_share":18.6819,"price_display":"18.68","price_state":"stated","total_value":383614.1346,"total_display":"383,614.13","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-17","filed_date":"2026-07-21","scope":"insider"},{"id":6169980,"accession":"0001168404-26-000029","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001168404-26-000029","line_url":"/filing/0001168404-26-000029#line-5","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2021, L.P.; GV 2021 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19595.0,"shares_display":"19,595","price_per_share":18.7297,"price_display":"18.73","price_state":"stated","total_value":367008.4715,"total_display":"367,008.47","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-16","filed_date":"2026-07-17","scope":"insider"},{"id":6169967,"accession":"0001168404-26-000029","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001168404-26-000029","line_url":"/filing/0001168404-26-000029#line-3","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2021, L.P.; GV 2021 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61992.0,"shares_display":"61,992","price_per_share":19.8376,"price_display":"19.84","price_state":"stated","total_value":1229772.4992,"total_display":"1,229,772.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-15","filed_date":"2026-07-17","scope":"insider"},{"id":6169964,"accession":"0001168404-26-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001168404-26-000029","line_url":"/filing/0001168404-26-000029#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2021, L.P.; GV 2021 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":18.793,"price_display":"18.79","price_state":"stated","total_value":234912.5,"total_display":"234,912.50","shares_owned_after":61992.0,"shares_owned_after_display":"61,992","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-15","filed_date":"2026-07-17","scope":"insider"},{"id":5781843,"accession":"0001168404-26-000025","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001168404-26-000025","line_url":"/filing/0001168404-26-000025#line-5","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2019 GP, L.P.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.; GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45410.0,"shares_display":"45,410","price_per_share":23.2691,"price_display":"23.27","price_state":"stated","total_value":1056649.831,"total_display":"1,056,649.83","shares_owned_after":42065.0,"shares_owned_after_display":"42,065","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-18","scope":"insider"},{"id":5781842,"accession":"0001168404-26-000025","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001168404-26-000025","line_url":"/filing/0001168404-26-000025#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2019 GP, L.P.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.; GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42065.0,"shares_display":"42,065","price_per_share":24.2679,"price_display":"24.27","price_state":"stated","total_value":1020829.2135,"total_display":"1,020,829.21","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-18","scope":"insider"},{"id":5781840,"accession":"0001168404-26-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001168404-26-000025","line_url":"/filing/0001168404-26-000025#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2019 GP, L.P.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.; GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60077.0,"shares_display":"60,077","price_per_share":23.0093,"price_display":"23.01","price_state":"stated","total_value":1382329.7161,"total_display":"1,382,329.72","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-18","scope":"insider"},{"id":5821726,"accession":"0001168404-26-000007","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001168404-26-000007","line_url":"/filing/0001168404-26-000007#line-5","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; Alphabet Inc.; GV 2017 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.P.; GV 2017, L.P.; GV 2021 GP, L.L.C.; GV 2019 GP, L.L.C.; GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1755632.0,"shares_display":"1,755,632","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":33357008.0,"total_display":"33,357,008.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-01-30","scope":"insider"},{"id":5821723,"accession":"0001168404-26-000007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001168404-26-000007","line_url":"/filing/0001168404-26-000007#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; Alphabet Inc.; GV 2017 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.P.; GV 2017, L.P.; GV 2021 GP, L.L.C.; GV 2019 GP, L.L.C.; GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89676.0,"shares_display":"89,676","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":1703844.0,"total_display":"1,703,844.00","shares_owned_after":3198249.0,"shares_owned_after_display":"3,198,249","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-01-30","scope":"insider"},{"id":5155131,"accession":"0001415889-25-021025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-021025","line_url":"/filing/0001415889-25-021025#line-1","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; Alphabet Inc.; GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":3.3,"price_display":"3.30","price_state":"stated","total_value":4950000.0,"total_display":"4,950,000.00","shares_owned_after":3262440.0,"shares_owned_after_display":"3,262,440","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-01","filed_date":"2025-08-05","scope":"insider"},{"id":7856833,"accession":"0000929638-23-002316","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000929638-23-002316","line_url":"/filing/0000929638-23-002316#line-3","is_derivative":false,"issuer_cik":"0001568651","issuer_name":"Oscar Health, Inc.","issuer_ticker":"OSCR","issuer_name_source":null,"issuer_url":"/issuer/0001568651","owner_cik":null,"owner_name":"Alphabet Holdings LLC; Alphabet Inc.; CapitalG 2015 GP LLC; CapitalG 2015 LP; CapitalG GP LLC; CapitalG LP; GV 2014 GP, L.L.C.; GV 2014, L.P.; Verily Life Sciences LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5719438.0,"shares_display":"5,719,438","price_per_share":8.081,"price_display":"8.08","price_state":"stated","total_value":46218778.478,"total_display":"46,218,778.48","shares_owned_after":15625310.0,"shares_owned_after_display":"15,625,310","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-17","filed_date":"2023-08-21","scope":"insider"},{"id":7856827,"accession":"0000929638-23-002316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-23-002316","line_url":"/filing/0000929638-23-002316#line-2","is_derivative":false,"issuer_cik":"0001568651","issuer_name":"Oscar Health, Inc.","issuer_ticker":"OSCR","issuer_name_source":null,"issuer_url":"/issuer/0001568651","owner_cik":null,"owner_name":"Alphabet Holdings LLC; Alphabet Inc.; CapitalG 2015 GP LLC; CapitalG 2015 LP; CapitalG GP LLC; CapitalG LP; GV 2014 GP, L.L.C.; GV 2014, L.P.; Verily Life Sciences LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":525470.0,"shares_display":"525,470","price_per_share":8.081,"price_display":"8.08","price_state":"stated","total_value":4246323.07,"total_display":"4,246,323.07","shares_owned_after":1180474.0,"shares_owned_after_display":"1,180,474","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-17","filed_date":"2023-08-21","scope":"insider"},{"id":7856823,"accession":"0000929638-23-002316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-23-002316","line_url":"/filing/0000929638-23-002316#line-1","is_derivative":false,"issuer_cik":"0001568651","issuer_name":"Oscar Health, Inc.","issuer_ticker":"OSCR","issuer_name_source":null,"issuer_url":"/issuer/0001568651","owner_cik":null,"owner_name":"Alphabet Holdings LLC; Alphabet Inc.; CapitalG 2015 GP LLC; CapitalG 2015 LP; CapitalG GP LLC; CapitalG LP; GV 2014 GP, L.L.C.; GV 2014, L.P.; Verily Life Sciences LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":255092.0,"shares_display":"255,092","price_per_share":8.081,"price_display":"8.08","price_state":"stated","total_value":2061398.452,"total_display":"2,061,398.45","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-17","filed_date":"2023-08-21","scope":"insider"},{"id":7922601,"accession":"0001209191-23-039122","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-039122","line_url":"/filing/0001209191-23-039122#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; Alphabet Inc.; GV 2021, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19003.0,"shares_display":"19,003","price_per_share":14.9711,"price_display":"14.97","price_state":"stated","total_value":284495.8133,"total_display":"284,495.81","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-22","scope":"insider"},{"id":7922595,"accession":"0001209191-23-039122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-039122","line_url":"/filing/0001209191-23-039122#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; Alphabet Inc.; GV 2021, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37405.0,"shares_display":"37,405","price_per_share":15.0581,"price_display":"15.06","price_state":"stated","total_value":563248.2305,"total_display":"563,248.23","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"},{"id":7972549,"accession":"0001209191-23-038363","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-038363","line_url":"/filing/0001209191-23-038363#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2021, L.P.; Alphabet Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6532.0,"shares_display":"6,532","price_per_share":15.0198,"price_display":"15.02","price_state":"stated","total_value":98109.3336,"total_display":"98,109.33","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-20","scope":"insider"},{"id":7972543,"accession":"0001209191-23-038363","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-038363","line_url":"/filing/0001209191-23-038363#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2021, L.P.; Alphabet Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66659.0,"shares_display":"66,659","price_per_share":14.9166,"price_display":"14.92","price_state":"stated","total_value":994325.6394,"total_display":"994,325.64","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-20","scope":"insider"},{"id":7922480,"accession":"0001209191-23-037334","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-037334","line_url":"/filing/0001209191-23-037334#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; Alphabet Inc.; GV 2019, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28960.0,"shares_display":"28,960","price_per_share":14.8717,"price_display":"14.87","price_state":"stated","total_value":430684.432,"total_display":"430,684.43","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-15","scope":"insider"},{"id":7922473,"accession":"0001209191-23-037334","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-037334","line_url":"/filing/0001209191-23-037334#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; Alphabet Inc.; GV 2019, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28100.0,"shares_display":"28,100","price_per_share":15.1282,"price_display":"15.13","price_state":"stated","total_value":425102.42,"total_display":"425,102.42","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider"},{"id":8723932,"accession":"0001209191-23-036666","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-036666","line_url":"/filing/0001209191-23-036666#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.; Alphabet Inc.; GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16031.0,"shares_display":"16,031","price_per_share":14.9804,"price_display":"14.98","price_state":"stated","total_value":240150.7924,"total_display":"240,150.79","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-13","scope":"insider"},{"id":8723928,"accession":"0001209191-23-036666","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-036666","line_url":"/filing/0001209191-23-036666#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.; Alphabet Inc.; GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15672.0,"shares_display":"15,672","price_per_share":14.4834,"price_display":"14.48","price_state":"stated","total_value":226983.8448,"total_display":"226,983.84","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-09","filed_date":"2023-06-13","scope":"insider"},{"id":8723910,"accession":"0001209191-23-035849","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-035849","line_url":"/filing/0001209191-23-035849#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.; Alphabet Inc.; GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.7373,"price_display":"15.74","price_state":"stated","total_value":78686.5,"total_display":"78,686.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-09","scope":"insider"},{"id":8723906,"accession":"0001209191-23-035849","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-035849","line_url":"/filing/0001209191-23-035849#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.; Alphabet Inc.; GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":16.9247,"price_display":"16.92","price_state":"stated","total_value":253870.5,"total_display":"253,870.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-09","scope":"insider"},{"id":8403930,"accession":"0001209191-23-035068","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-035068","line_url":"/filing/0001209191-23-035068#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29975.0,"shares_display":"29,975","price_per_share":17.0197,"price_display":"17.02","price_state":"stated","total_value":510165.5075,"total_display":"510,165.51","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-07","scope":"insider"},{"id":8403924,"accession":"0001209191-23-035068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-035068","line_url":"/filing/0001209191-23-035068#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22434.0,"shares_display":"22,434","price_per_share":16.6984,"price_display":"16.70","price_state":"stated","total_value":374611.9056,"total_display":"374,611.91","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-07","scope":"insider"},{"id":8042906,"accession":"0001209191-23-033697","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-033697","line_url":"/filing/0001209191-23-033697#line-5","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; GV 2019 GP, L.P.; Alphabet Inc.; GV 2021, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44752.0,"shares_display":"44,752","price_per_share":14.3512,"price_display":"14.35","price_state":"stated","total_value":642244.9024,"total_display":"642,244.90","shares_owned_after":471.0,"shares_owned_after_display":"471","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-02","scope":"insider"},{"id":8042903,"accession":"0001209191-23-033697","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-033697","line_url":"/filing/0001209191-23-033697#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; GV 2019 GP, L.P.; Alphabet Inc.; GV 2021, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":471.0,"shares_display":"471","price_per_share":14.7534,"price_display":"14.75","price_state":"stated","total_value":6948.8514,"total_display":"6,948.85","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-02","scope":"insider"},{"id":8042897,"accession":"0001209191-23-033697","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-033697","line_url":"/filing/0001209191-23-033697#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; GV 2019 GP, L.P.; Alphabet Inc.; GV 2021, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16633.0,"shares_display":"16,633","price_per_share":13.6478,"price_display":"13.65","price_state":"stated","total_value":227003.8574,"total_display":"227,003.86","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-02","scope":"insider"},{"id":8545335,"accession":"0001209191-23-033107","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-033107","line_url":"/filing/0001209191-23-033107#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; GV 2019, L.P.; GV 2019 GP, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.; GV 2019 GP, L.L.C.; Alphabet Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16805.0,"shares_display":"16,805","price_per_share":13.7007,"price_display":"13.70","price_state":"stated","total_value":230240.2635,"total_display":"230,240.26","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-30","filed_date":"2023-05-31","scope":"insider"},{"id":8545329,"accession":"0001209191-23-033107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-033107","line_url":"/filing/0001209191-23-033107#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; GV 2019, L.P.; GV 2019 GP, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.; GV 2019 GP, L.L.C.; Alphabet Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12602.0,"shares_display":"12,602","price_per_share":13.6965,"price_display":"13.70","price_state":"stated","total_value":172603.293,"total_display":"172,603.29","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-26","filed_date":"2023-05-31","scope":"insider"},{"id":8438864,"accession":"0001209191-23-032529","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-032529","line_url":"/filing/0001209191-23-032529#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23161.0,"shares_display":"23,161","price_per_share":13.3834,"price_display":"13.38","price_state":"stated","total_value":309972.9274,"total_display":"309,972.93","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-25","filed_date":"2023-05-26","scope":"insider"},{"id":8438857,"accession":"0001209191-23-032529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-032529","line_url":"/filing/0001209191-23-032529#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7900.0,"shares_display":"7,900","price_per_share":13.6608,"price_display":"13.66","price_state":"stated","total_value":107920.32,"total_display":"107,920.32","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-24","filed_date":"2023-05-26","scope":"insider"},{"id":8679731,"accession":"0001209191-23-031916","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-031916","line_url":"/filing/0001209191-23-031916#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; GV 2021, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2019, L.P.; Alphabet Inc.; GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43939.0,"shares_display":"43,939","price_per_share":14.7397,"price_display":"14.74","price_state":"stated","total_value":647647.6783,"total_display":"647,647.68","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-05-24","scope":"insider"},{"id":8679727,"accession":"0001209191-23-031916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-031916","line_url":"/filing/0001209191-23-031916#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; GV 2021, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2019, L.P.; Alphabet Inc.; GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87922.0,"shares_display":"87,922","price_per_share":14.1272,"price_display":"14.13","price_state":"stated","total_value":1242091.6784,"total_display":"1,242,091.68","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-24","scope":"insider"},{"id":8703157,"accession":"0001209191-23-031450","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-031450","line_url":"/filing/0001209191-23-031450#line-5","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63212.0,"shares_display":"63,212","price_per_share":13.875,"price_display":"13.88","price_state":"stated","total_value":877066.5,"total_display":"877,066.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-19","filed_date":"2023-05-22","scope":"insider"},{"id":8703150,"accession":"0001209191-23-031450","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-031450","line_url":"/filing/0001209191-23-031450#line-3","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14022.0,"shares_display":"14,022","price_per_share":13.0631,"price_display":"13.06","price_state":"stated","total_value":183170.7882,"total_display":"183,170.79","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-22","scope":"insider"},{"id":8703147,"accession":"0001209191-23-031450","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-031450","line_url":"/filing/0001209191-23-031450#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13076.0,"shares_display":"13,076","price_per_share":13.0086,"price_display":"13.01","price_state":"stated","total_value":170100.4536,"total_display":"170,100.45","shares_owned_after":10722248.0,"shares_owned_after_display":"10,722,248","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-22","scope":"insider"},{"id":8652586,"accession":"0001209191-23-030621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-030621","line_url":"/filing/0001209191-23-030621#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2019 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":12.7733,"price_display":"12.77","price_state":"stated","total_value":191599.5,"total_display":"191,599.50","shares_owned_after":10735324.0,"shares_owned_after_display":"10,735,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-18","scope":"insider"},{"id":8652583,"accession":"0001209191-23-030621","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030621","line_url":"/filing/0001209191-23-030621#line-1","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2019 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50649.0,"shares_display":"50,649","price_per_share":12.5901,"price_display":"12.59","price_state":"stated","total_value":637675.9749,"total_display":"637,675.97","shares_owned_after":10750324.0,"shares_owned_after_display":"10,750,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":7835256,"accession":"0001209191-23-029789","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-029789","line_url":"/filing/0001209191-23-029789#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; Alphabet Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":157952.0,"shares_display":"157,952","price_per_share":12.7386,"price_display":"12.74","price_state":"stated","total_value":2012087.3472,"total_display":"2,012,087.35","shares_owned_after":10800973.0,"shares_owned_after_display":"10,800,973","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-16","scope":"insider"},{"id":7835253,"accession":"0001209191-23-029789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-029789","line_url":"/filing/0001209191-23-029789#line-1","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; Alphabet Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27290.0,"shares_display":"27,290","price_per_share":12.7234,"price_display":"12.72","price_state":"stated","total_value":347221.586,"total_display":"347,221.59","shares_owned_after":10958925.0,"shares_owned_after_display":"10,958,925","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-12","filed_date":"2023-05-16","scope":"insider"},{"id":8679525,"accession":"0001209191-23-029033","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-029033","line_url":"/filing/0001209191-23-029033#line-3","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21819.0,"shares_display":"21,819","price_per_share":12.9815,"price_display":"12.98","price_state":"stated","total_value":283243.3485,"total_display":"283,243.35","shares_owned_after":10991022.0,"shares_owned_after_display":"10,991,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-11","filed_date":"2023-05-12","scope":"insider"}],"next_cursor":"2023-05-11|8679525","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001788451","name":"Ethos Technologies Inc.","url":"/issuer/0001788451","role":"Ten percent owner","n_filings":7,"first_seen":"2026-01-30","last_seen":"2026-07-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001894562","name":"Prime Medicine, Inc.","url":"/issuer/0001894562","role":"Ten percent owner, Other","n_filings":17,"first_seen":"2022-10-26","last_seen":"2025-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001568651","name":"Oscar Health, Inc.","url":"/issuer/0001568651","role":"Ten percent owner","n_filings":1,"first_seen":"2023-08-21","last_seen":"2023-08-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001653482","name":"Gitlab Inc.","url":"/issuer/0001653482","role":"Other","n_filings":8,"first_seen":"2022-05-12","last_seen":"2023-05-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001840574","name":"Verve Therapeutics, Inc.","url":"/issuer/0001840574","role":"Other","n_filings":3,"first_seen":"2022-11-02","last_seen":"2022-11-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001824920","name":"IonQ, Inc.","url":"/issuer/0001824920","role":"Ten percent owner","n_filings":1,"first_seen":"2022-04-12","last_seen":"2022-04-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001562088","name":"Duolingo, Inc.","url":"/issuer/0001562088","role":"Ten percent owner","n_filings":8,"first_seen":"2021-08-02","last_seen":"2022-02-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001544522","name":"Freshworks Inc.","url":"/issuer/0001544522","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2021-11-18","last_seen":"2021-11-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001535527","name":"CrowdStrike Holdings, Inc.","url":"/issuer/0001535527","role":"Ten percent owner","n_filings":12,"first_seen":"2019-06-18","last_seen":"2020-02-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001652044","retrieved_at":"2026-08-20T17:05:37+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}